SCHEMBL563386

SCHEMBL563386

NC1=NS(=O)(=O)N(Cc2ccccc2)c2nc(C3CCCCC3)n(Cc3ccccc3)c21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
USP2 O75604 1/20 0.39
POLB P06746 1/20 0.39
ATM Q13315 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
KCNH2 Q12809 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
CYP19A1 P11511 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PDE2A O00408 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563046 0.78 ALDH1A1 (0.46) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL10018158 0.77 KMT2A (0.46) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL562165 0.73 ALDH1A1 (0.49) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL10018160 0.73 KDM4E (0.42) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL562684 0.72 ALDH1A1 (0.50) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL8801413 0.68 MAPT (0.37) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL10018161 0.67 TLR7 (0.38) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL11100209 0.64 KMT2A (0.51) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL29412084 0.64 PARP1 (0.53) KMT2AALDH1A1KDM4EMEN1LMNA
SCHEMBL28493359 0.64 PARP1 (0.53) KMT2AALDH1A1KDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US claimed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US claimed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP claimed
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US disclosed
US-8815846-B2 Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) 2014-08-26 US disclosed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US disclosed
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) 2012-02-09 US disclosed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP disclosed
EP-2392577-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2011-12-07 EP disclosed
WO-2010086481-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035160-A1 NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE THOC2, TUBGCP2, TBC1D5 KMT2A 1719/4885ALDH1A1 1329/4885KDM4E 2538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.